4//SEC Filing
WRIGHT TIMOTHY MICHAEL 4
Accession 0001209191-19-007778
CIK 0001505512other
Filed
Feb 5, 7:00 PM ET
Accepted
Feb 6, 4:52 PM ET
Size
7.3 KB
Accession
0001209191-19-007778
Insider Transaction Report
Form 4
WRIGHT TIMOTHY MICHAEL
Chief R & D Officer
Transactions
- Award
Stock Option (Right to Buy)
2019-02-05+40,000→ 40,000 totalExercise: $0.95Exp: 2029-02-04→ Common Stock (40,000 underlying) - Award
Common Stock
2019-02-05$0.95/sh+40,000$38,000→ 62,893 total
Footnotes (2)
- [F1]Restricted Stock Units which vest ratably on a quarterly basis such that the grant is fully vested on December 31, 2019, subject to the reporting person's continuous service to Regulus through each such vesting date.
- [F2]The stock option will vest ratably on a monthly basis over a 48 month period subject to the reporting person's continuous service to Regulus through each such vesting date.
Documents
Issuer
Regulus Therapeutics Inc.
CIK 0001505512
Entity typeother
Related Parties
1- filerCIK 0001686178
Filing Metadata
- Form type
- 4
- Filed
- Feb 5, 7:00 PM ET
- Accepted
- Feb 6, 4:52 PM ET
- Size
- 7.3 KB